Pharma & Biotech

Creates a judiciary-enforced four-month deadline for resolving the Ribociclib patent dispute and mandates a timeline-based SOP that formalizes expedited processing and prioritization of patent applications.

The agreement assigns semi‑exclusive co‑marketing rights and payment obligations to Lupin and places manufacturing and primary marketing responsibilities with Zydus, creating defined commercial and supply responsibilities for both firms in India.

Packaging for all antimicrobial drugs must include a conspicuous blue vertical strip along the left side running the full label and cannot obscure other required label information.

Concentrates WHO‑qualified end‑to‑end manufacturing for nOPV2 at a single integrated site, centralizing regulatory qualification and narrowing the set of WHO‑qualified suppliers for that vaccine.

The order creates a regulatory prohibition on importing, distributing, and administering that rivastigmine formulation in China, removing it from Chinese pharmaceutical supply and clinical use channels.

President Trump announced a deal with Pfizer to reduce drug prices for Medicaid patients, implementing a 'most-favored-nation' pricing model. Pfizer will sell medications at significantly lower prices and invest $70 billion in U.S. manufacturing. The agreement aims to benefit American patients and avoid tariffs on pharmaceuticals.